MAXCYTE, INC.·4

Sep 18, 4:34 PM ET

Soleymannezhad Ali 4

4 · MAXCYTE, INC. · Filed Sep 18, 2024

Insider Transaction Report

Form 4
Period: 2024-09-16
Soleymannezhad Ali
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-09-16+10,40026,025 total
  • Award

    Employee Stock Option (right to buy)

    2024-09-16+20,80020,800 total
    Exercise: $4.12Exp: 2034-09-15Common Stock (20,800 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on September 16, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
  • [F2]Twenty-five percent (25%) of the shares underlying this option shall vest on September 16, 2025, and the remainder shall vest in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary